Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy.

MLA

Brown, Rebecca J., et al. “Long-Term Effectiveness and Safety of Metreleptin in the Treatment of Patients with Generalized Lipodystrophy.” Endocrine, vol. 60, no. 3, June 2018, pp. 479–89. EBSCOhost, https://doi.org/10.1007/s12020-018-1589-1.

APA

Brown, R. J., Oral, E. A., Cochran, E., Araújo-Vilar, D., Savage, D. B., Long, A., Fine, G., Salinardi, T., & Gorden, P. (2018). Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy. Endocrine, 60(3), 479–489. https://doi.org/10.1007/s12020-018-1589-1

Chicago

Brown, Rebecca J, Elif A Oral, Elaine Cochran, David Araújo-Vilar, David B Savage, Alison Long, Gregory Fine, Taylor Salinardi, and Phillip Gorden. 2018. “Long-Term Effectiveness and Safety of Metreleptin in the Treatment of Patients with Generalized Lipodystrophy.” Endocrine 60 (3): 479–89. doi:10.1007/s12020-018-1589-1.